ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ATAI ATAI Life Sciences NV

1.92
0.13 (7.26%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2,959,300
Bid Price 1.92
Ask Price 2.02
News (1)
Day High 2.04

Low
1.025

52 Week Range

High
2.39

Day Low 1.80
Company Name Stock Ticker Symbol Market Type
ATAI Life Sciences NV ATAI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.13 7.26% 1.92 19:43:54
Open Price Low Price High Price Close Price Prev Close
1.805 1.80 2.04 1.97 1.79
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
10,211 2,959,300 $ 1.95 $ 5,772,392 - 1.025 - 2.39
Last Trade Time Type Quantity Stock Price Currency
19:43:54 formt 435 $ 1.92 USD

ATAI Life Sciences NV Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
327.04M 166.01M - 233k -152.39M -0.92 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ATAI Life Sciences NV News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ATAI Message Board. Create One! See More Posts on ATAI Message Board See More Message Board Posts

Historical ATAI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.722.041.601.701,076,0250.2011.63%
1 Month2.002.3151.581.911,582,903-0.08-4.00%
3 Months1.602.3151.511.891,472,6020.3220.00%
6 Months1.342.3151.0251.651,124,8990.5843.28%
1 Year1.402.391.0251.731,045,9360.5237.14%
3 Years21.0022.911.0254.07936,296-19.08-90.86%
5 Years1.0322.910.983.85959,8850.8986.41%

ATAI Life Sciences NV Description

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

Your Recent History

Delayed Upgrade Clock